NDC 51808-210

Dextran 75

Dextran 75

Dextran 75 is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Dextran 75.

• Product ID: 51808-210_29c1fd45-7d77-4882-9e73-8a66742be742
• NDC: 51808-210
• Product Type: Human Prescription Drug
• Proprietary Name: Dextran 75
• Generic Name: Dextran 75
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2012-07-01
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: AnazaoHealth Corporation
• Substance Name: DEXTRAN 75
• Active Ingredient Strength: 10 mg/1
• Pharm Classes: Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 51808-210-01

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 KIT (51808-210-01)

• Marketing Start Date: 2012-07-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51808-210-01 [51808021001]

Dextran 75 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: Unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2012-07-01
• Inactivation Date: 2019-11-27

Drug Details

Active Ingredients

Ingredient	Strength
DEXTRAN 75	10 mg/1

OpenFDA Data

• SPL SET ID: a71129ae-8266-4064-a3f5-6f2897e62981
• Manufacturer:
  • AnazaoHealth Corporation
• UNII:
  • JY83SHX053

Pharmacological Class

• Plasma Volume Expander [EPC]
• Increased Intravascular Volume [PE]
• Osmotic Activity [MoA]